Skip to main content
. 2023 Feb 21;49(2):157–166. doi: 10.1134/S1068162023020139

Table 1.  .

The main difference between Traditional Drug Discovery System and Drug Repurposing [613]

TRADITIONAL DRUG DISCOVERY DRUG REPURPOSING

Include 5 stages:

  • Discovery and preclinical

  • Safety review

  • Clinical research

  • FDA review

  • FDA post-market safety monitoring

Include 4 stages:

    • Compound identification

    • Compound acquisition

    • Development

    • FDA post-market safety monitoring

Generally, more time consuming Less time consuming
High investment or cost Lesser investment compared to traditional drug discovery
More risk of failure Less risk of failure
Clinical efficacy and safety profile should be evaluated Clinical efficacy and safety profiles already exist

Repurposing drugs have a significant advantage in decreasing the development cost and time to market over standard discovery. Data like pharmacokinetics, toxicology, and safety data from the standard discovery process [1416].